Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The New England Journal of Medicine
|
January 6, 2006
Clinical problem-solving. Needle in a haystack
Krishna R Polu, Myles Wolf
Expert Opinion on Biological Therapy
|
May 22, 2014
Probody therapeutics for targeting antibodies to diseased tissue
Krishna R Polu, Henry B Lowman
BMC Nephrology
|
September 1, 2012
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
Anatole Besarab, Steven N Zeig, Edouard R Martin, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 24, 2011
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients
Iain C Macdougall, Andrzej Wiecek, Beatriz Tucker, et al.
The New England Journal of Medicine
|
January 25, 2013
Peginesatide in patients with anemia undergoing hemodialysis
Steven Fishbane, Brigitte Schiller, Francesco Locatelli, et al.
The New England Journal of Medicine
|
January 25, 2013
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis
Iain C Macdougall, Robert Provenzano, Amit Sharma, et al.
European Journal of Heart Failure
|
July 28, 2009
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
John J V McMurray, Inder S Anand, Rafael Diaz, et al.
Nature Genetics
|
June 1, 2005
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function
Jochen Reiser, Krishna R Polu, Clemens C Möller, et al.
The Journal of Clinical Investigation
|
January 4, 2022
The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses
Samantha A Chalmers, Rajalakshmy Ayilam Ramachandran, Sayra J Garcia, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The New England Journal of Medicine
|
January 6, 2006
Clinical problem-solving. Needle in a haystack
Krishna R Polu, Myles Wolf
Expert Opinion on Biological Therapy
|
May 22, 2014
Probody therapeutics for targeting antibodies to diseased tissue
Krishna R Polu, Henry B Lowman
BMC Nephrology
|
September 1, 2012
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients
Anatole Besarab, Steven N Zeig, Edouard R Martin, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 24, 2011
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients
Iain C Macdougall, Andrzej Wiecek, Beatriz Tucker, et al.
The New England Journal of Medicine
|
January 25, 2013
Peginesatide in patients with anemia undergoing hemodialysis
Steven Fishbane, Brigitte Schiller, Francesco Locatelli, et al.
The New England Journal of Medicine
|
January 25, 2013
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis
Iain C Macdougall, Robert Provenzano, Amit Sharma, et al.
European Journal of Heart Failure
|
July 28, 2009
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial
John J V McMurray, Inder S Anand, Rafael Diaz, et al.
Nature Genetics
|
June 1, 2005
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function
Jochen Reiser, Krishna R Polu, Clemens C Möller, et al.
The Journal of Clinical Investigation
|
January 4, 2022
The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses
Samantha A Chalmers, Rajalakshmy Ayilam Ramachandran, Sayra J Garcia, et al.
Page
of 1